Sapphire Medical Clinics and Dendrite Clinical Systems have launched the UK Medical Cannabis Registry, an initiative that is designed to rapidly expand the evidence base for medical cannabis in the UK and decrease the cost of access for patients. The launch will collect and analyse clinical information on patients taking medical cannabis treatments for all recognised eligible conditions.
“I am very pleased to report that demand for the Dendrite Web-Registry platform has reached an all-time high” Dr Peter Walton, Managing Director of Dendrite Clinical System. “We’re receiving new orders for new national and international registries every few days now – for surgical registries, medical registries, rare disease registries, medical device registries and Coronavirus Registries (for a range of Community, National, International and Global Covid-19 Registries).”
Sapphire Medical Clinics and Dendrite Clinical Systems have established the UK’s first national UK’s first comprehensive medical cannabis patient registry - UK Medical Cannabis Registry. The UK Medical Cannabis Registry will be the first of its kind covering all conditions for which there is evidence of clinical efficacy of medical cannabis. The formation of the registry means that real world evidence, cited as a key barrier to wider patient prescriptions by NHS England, will now be available on request to the medical community for analysis.
The British Association of Plastic, Reconstructive and Aesthetic Surgeons (BAPRAS), in conjunction with Dendrite Clinical Systems, is delighted to announce the release of the First UK National Flap Registry (UKNFR) Report. The UKNFR, which was launched in August 2015, collects information on all major free and pedicled flap operations carried out in the UK.
Dendrite Clinical Systems, the publisher of Bariatric News, has announced the publication of the Bariatric News Industry and Product Guide 2019 – a comprehensive A-Z guide to companies, products and services within the bariatric and metabolic specialty. 
Dendrite Clinical Systems, the publisher of Bariatric News, is pleased to announce issue 39 of the newspaper is now available to view/download. The newspaper reports on research, technology, events and policy in the bariatric specialty, the latest clinical studies, policy changes and product news, the latest meetings and events, interviews prominent bariatric experts, and host debates between specialists on controversial topics.
Dendrite Clinical Systems’ innovative “Intellect Web” software collecting COVID-19 data
Dendrite Clinical Systems’ innovative “Intellect Web” software has been utilised by several national and international organisations to establish web-based registries to collect data from patients with COVID-19.
“Our flexible software has been adapted and utilised across an array of specialities and clinical settings to investigate and record COVID-19 symptoms by teams of international researchers all over the world,” said Dr Peter Walton, Managing Director of Dendrite Clinical Systems. “As a company, we are working with our healthcare partners to enable them to record and report vital patient data and find different treatment strategies to help patients and healthcare systems overcome this devastating virus.”
The company is currently working with an international group of 17 leading diabetes experts from the multidisciplinary Diabetes Surgery Summit (DSS), as part of the CoviDiab project, which is collecting new cases of diabetes in patients with COVID-19. The aim of the CoviDiab Registry is to understand the extent and the characteristics of the manifestations of diabetes in patients with COVID-19, and the best strategies for the treatment and monitoring of affected patients, during and after the pandemic.
Dendrite is also working with the Institute for Health Research (IGES, Berlin) on the Outpatient Treatment of COVID-19 Infections (ABC-19) study that is recording data on treatment of COVID-19 patients to discover more about outpatient course of COVID-19. Study will help establish evidence-based guidelines for outpatient treatment, leading to improved outcomes & prevent unnecessary hospital admissions. Registry collects data from patients using smartphone/tablets via Dendrite’s e-PROMS module (patient-reported outcome measures) allowing patients who are isolating to remotely enter their data directly into the registry at their own convenience – 1st data are expected at the end of 2nd quarter of 2021.
Last year, our software was used in the Finding Out if COVID-19 Infection Can be pREdicted by ChAnges in Smell and/or Taste (FORECAST) study, led by Professor Rachel Batterham from the University College London and the University College London Hospitals NHS Foundation Trust, London, UK. The outcomes from the FORECAST study was the first to confirm that the loss of smell and/or taste are highly-reliable indicators that someone is likely to have Covid-19. The study also utilised our ePROMs software to collect data directly from patients.
Dendrite can provide you with a clinical software solution to help you collect your #COVID-19 data. Contact us today to learn more.
